Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:790-795
Published online before print January 19, 2006, doi: 10.1161/01.STR.0000202624.89869.e9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/3/790    most recent
01.STR.0000202624.89869.e9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elkind, M. S.V.
Right arrow Articles by Di Tullio, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elkind, M. S.V.
Right arrow Articles by Di Tullio, M. R.
Related Collections
Right arrowRelated Article

(Stroke. 2006;37:790.)
© 2006 American Heart Association, Inc.


Original Contributions

Seropositivity to Chlamydia pneumoniae Is Associated With Risk of First Ischemic Stroke

Mitchell S.V. Elkind, MD, MS; Maria Lucia C. Tondella, PhD; Daniel R. Feikin, MD, MSPH; Barry S. Fields, PhD; Shunichi Homma, MD Marco R. Di Tullio, MD

From the Departments of Neurology (M.S.V.E.) and Medicine (S.H., M.R.DT.), College of Physicians and Surgeons, Columbia University, and the Columbia University Medical Center of New York-Presbyterian Hospital, New York, NY; Gertrude H. Sergievsky Center (M.S.V.E.), College of Physicians and Surgeons, Columbia University, New York, NY; and Respiratory Diseases Branch (M.L.C.T., D.R.F., B.S.F.), Centers for Disease Control and Prevention, Atlanta, Ga.

Correspondence to Mitchell S.V. Elkind, MD, Neurological Institute, 710 W 168th St, New York, NY 10032. E-mail mse13{at}columbia.edu

Background and Purpose— Serologic evidence of infection with Chlamydia pneumoniae has been associated with cardiovascular disease, but its relationship with stroke risk remains uncertain. The objective of this study is to determine whether serological evidence of C pneumoniae infection is associated with risk of ischemic stroke.

Methods— A population-based case-control study was performed in an urban, multiethnic population. Cases (n=246) had first ischemic stroke, and controls (n=474) matched for age, sex, and race–ethnicity were derived through random-digit dialing. Titers of C pneumoniae–specific IgG and IgA antibodies were measured using microimmunofluorescence, and positive titers were prospectively defined. Conditional logistic regression was used to calculate odds ratios (ORs) and 95% CIs adjusting for medical, behavioral, and socioeconomic factors.

Results— Mean age among cases was 72.3±9.7 years; 50.8% were women. Elevated C pneumoniae IgA titers were associated with increased risk of ischemic stroke after adjusting for hypertension, diabetes mellitus, current cigarette use, atrial fibrillation, and levels of high-density lipoprotein and low-density lipoprotein (adjusted OR, 1.5; 95% CI, 1.0 to 2.2). Elevated IgG titers were not associated with stroke risk (adjusted OR, 1.2; 95% CI, 0.8 to 1.8). There was a trend toward an association of elevated IgA titers with atherosclerotic and lacunar stroke but less so cardioembolic or cryptogenic subtypes.

Conclusions— Serologic evidence of C pneumoniae infection is associated with ischemic stroke risk. IgA titers may be a better marker of risk than IgG. This association is independent of other stroke risk factors and is present for atherosclerotic, lacunar, and cardioembolic subypes. Further studies of the effect of C pneumoniae on stroke risk are warranted.


Key Words: cerebrovascular disorders • Chlamydophila pneumoniae • risk factors • stroke, ischemic


Related Article:

Chlamydia pneumoniae, Stroke, and Serological Associations: Anything Learned From the Atherosclerosis-Cardiovascular Literature or Do We Have to Start Over Again?
Petra Apfalter
Stroke 2006 37: 756-758. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Mult SclerHome page
J. Parratt, R. Tavendale, J. O'Riordan, D. Parratt, and R. Swingler
Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis
Multiple Sclerosis, April 1, 2008; 14(3): 292 - 299.
[Abstract] [PDF]


Home page
StrokeHome page
P. Apfalter
Chlamydia pneumoniae, Stroke, and Serological Associations: Anything Learned From the Atherosclerosis-Cardiovascular Literature or Do We Have to Start Over Again?
Stroke, March 1, 2006; 37(3): 756 - 758.
[Full Text] [PDF]